Treatment of retinoblastoma has undergone significant advancements over the past few
decades, as globe-salvaging therapies with chemoreduction and focal consolidation are …

Background Retinoblastoma is the most common primary intraocular malignancy in children.
The management of retinoblastoma is complex and depends on several factors. Methods …

Background Retinoblastoma is a highly malignant tumor of the eye that manifests most often
in the first 3 years of life. Methods Published articles were reviewed to evaluate the clinical …

Retinoblastoma, the most common intraocular malignancy of childhood arises due to
mutation of the retinoblastoma gene on chromosome 13q14. In the hereditary setting this …

PURPOSE: To provide an overview of the current clinical management of retinoblastoma by
discussing the trends in the categorization, treatment, and recent advances in molecular …

Retinoblastoma (Rb) is the most common primary intraocular malignancy of childhood, but
an uncommon paediatric cancer, with a constant incidence worldwide of 1: 15,000–1 …

Purpose To review the progress made in understanding the genetic basis, molecular
pathology, and treatment of retinoblastoma since the previous Jackson lecture on the topic …

Progressive advances in the understanding of retinoblastoma pathogenesis continue to lead
treatment strategies. Improvements in the diagnosis and management of retinoblastoma are …

Retinoblastoma is a rare type of cancer of the eye, often developing in early childhood, that
affects the retina, the light sensitive tissue at the back of the eye that detects light and colour …

Retinoblastoma is the commonest primary ocular malignancy of childhood. There are two
forms—heritable and non heritable. Heritable retinoblastoma is a cancer susceptibility …